Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
the ONA take:
Actress Angelina Jolie announced Tuesday that she underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
Having lost her mother, grandmother, and aunt to cancer, Jolie underwent a double mastectomy 2 years ago over similar concerns. Jolie opted to have her ovaries and fallopian tubes last weeks after a blood test revealed that she may be in the early stages of cancer.
After Jolie underwent the procedure to remove both of her breasts, the pros and cons of preventative measures were pushed into the spotlight, ultimately causing the "Angelina Jolie effect," in which there was an increase in women with genuine concerns about their family history of breast cancer seeking advice from health care professionals. Her announcement could produce the same effect for women concerned about their risk of ovarian cancer.
Further tests showed that the actress was not actually in the early stages of cancer, but she opted for the surgery before of her family history and because she carries the BRCA1 gene mutation that increases her risk of developing ovarian cancer by 50% and breast cancer by 87%.
Actress Angelina Jolie underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|